Mepenex

Meropenem, the active ingredient in Mepenex, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and severe sepsis in hospitalized patients.

GNH USA supplies Mepenex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication. Complicated urinary tract infections: provides effective bacterial clearance. Nosocomial pneumonia: improves respiratory outcomes in hospital‑acquired cases. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. Severe sepsis and septic shock: supports rapid bacterial control in critical care.

Adverse reactions may occur with meropenem therapy and are categorized by frequency.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Headache - Rash - Elevated liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment - Anaphylactic reactions - Clostridioides difficile‑associated colitis - Neutropenia - Thrombocytopenia - Acute renal impairment

Meropenem requires careful monitoring in several clinical situations.

Renal function: adjust dose in patients with impaired renal function. Seizure risk: avoid in patients with a history of epilepsy or CNS disorders. Allergy history: assess for hypersensitivity to beta‑lactam antibiotics. Pregnancy and lactation: use only if the potential benefit justifies the potential risk. Drug‑resistant organisms: perform susceptibility testing before initiation. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: reduces meropenem plasma concentrations, compromising efficacy. - CNS depressants: may increase the risk of seizures when combined. - Nephrotoxic agents: concurrent use can exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Aminoglycosides: monitor renal function and drug levels. - Loop diuretics: watch for electrolyte disturbances. - Anticoagulants (e.g., warfarin): observe coagulation parameters for potential alterations.